EN DE
Watch Nissan for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Nissan (NISA) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Nissan stock ILS 10.11, price ILS 9.53, upside +6.1%, quality 53 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare Il · ISIN IL0006600196

N Some data Nov 3, 2026

Nissan

NISA · TA
Fairly valued, sideways

The stock costs about what our calculation considers fair.

Low debt
Generates free cash flow
Fair value 10.11 ILS · Fairly valued
Quality 53/100
Thin margins · 1.2% net margin (TTM)
0.2% dividend yield
Mixed vs. peers (6/14)
Some data
Revenue last quarter 20% below a year ago.
Weak Growth (revenue 5y −2.0 %/yr in ILS)
Narrow moat 34/100 · thin data
Watch Nissan for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

23.04 ILS 5.93 ILS Fair Value 10.11 ILS Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

60‑month range 5.93 ILS – 23.04 ILS · fair‑value band 8.00 ILS – 12.63 ILS · the 9.53 ILS price screens below the 10.11 ILS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. As of Nov 3, 2026.

Follow Nissan in your weekly email

Every Wednesday you see whether Nissan is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Nissan Medical Industries Ltd manufactures and markets spunlace non-woven fabrics in the United States, Canada, Europe, the Far East, Israel, and internationally.

Show moreShow less

Its products are used in reusable and consumable consumer products, medical products, automotive, infrastructure, hygienic, and other industries. The company sells its products through its sales agents. Nissan Medical Industries Ltd was incorporated in 1984 and is based in Tel Aviv-Yafo, Israel.

Stock analysis

Nissan (NISA) currently trades at 9.53 ILS, while our model-based Fair Value estimate is 10.11 ILS, so the stock looks roughly fairly valued today (gap 5.7%).

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 21.45 ILS per share, and 17 of the 24 models we run sit above the 9.53 ILS price.

Bear case: the Earnings-Based group reads lowest at 7.65 ILS, and 7 of the 24 models stay below the price. Data coverage for this calculation is medium.

Scenario range: 8.00 ILS (bear) to 12.63 ILS (bull), the price of 9.53 ILS sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 53/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

Nissan reported revenue of 652M ILS in FY2025 versus 668M ILS in FY2021, a compound −0.6%/yr. Reported net income was 4.2M ILS in FY2025, compounding −41.7%/yr from FY2021.

Key figures

Market cap 86.6M ILS Micro · P/E ratio 12.1 · P/S ratio 0.15 · EPS (TTM) 0.7900 ILS · Dividend yield 0.2% · Net margin 1.2% · Return on equity 4.6% · Return on assets (EBIT) 4.5% (5-year average).

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (low confidence).

What moves the price

The share trades about 14% below its 52-week high and 38% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 6%, NISA screens cheaper than that median.

Fair Value models

Bear 8.00 ILS Fair Value 10.11 ILS Bull 12.63 ILS
Price 9.53 ILS · Upside +6.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.6775 ILS per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 18.43 ILS 24.78 ILS 34.29 ILS 80
Growth DCF 18.97 ILS 24.97 ILS 33.45 ILS 78
Owner Earnings 17.73 ILS 23.86 ILS 33.03 ILS 76
All 24 models by family
DCF Models
FCF DCF 18.43 ILS 24.78 ILS 34.29 ILS 80
Owner Earnings 17.73 ILS 23.86 ILS 33.03 ILS 76
5Y Revenue Exit 12.68 ILS 17.42 ILS 23.60 ILS 72
5Y EBITDA Exit 20.28 ILS 30.54 ILS 42.82 ILS 74
5Y P/E Exit 10.80 ILS 14.17 ILS 17.77 ILS 71
10Y Revenue Exit 14.62 ILS 19.03 ILS 24.00 ILS 67
10Y EBITDA Exit 19.35 ILS 27.33 ILS 36.57 ILS 68
10Y P/E Exit 13.78 ILS 16.97 ILS 20.18 ILS 64
Earnings-Based
Graham-Dodd 3.12 ILS 5.97 ILS 7.45 ILS 66
EPV 8.00 ILS 9.32 ILS 10.44 ILS 73
Dividend Discount
Gordon GGM 7.28 ILS 9.70 ILS 12.00 ILS 69
DDM Multi-Stage 7.28 ILS 9.77 ILS 12.49 ILS 67
Multiples
P/E Multiple 7.58 ILS 10.11 ILS 12.63 ILS 63
P/S Multiple 5.86 ILS 7.81 ILS 9.76 ILS 57
P/B Multiple 58.63 ILS 78.17 ILS 97.72 ILS 55
EV/EBIT 5.57 ILS 10.46 ILS 15.34 ILS 62
EV/EBITDA 16.78 ILS 25.41 ILS 34.03 ILS 66
EV/Revenue 1.37 ILS 5.86 ILS 10.34 ILS 47
Asset-Based
NCAV (Graham) 0.1200 ILS 0.1800 ILS 0.2300 ILS 54
Growth DCF
Growth DCF 18.97 ILS 24.97 ILS 33.45 ILS 78
Rev-Margin DCF 12.68 ILS 17.80 ILS 23.76 ILS 72
Economic Profit
Residual Income 13.89 ILS 14.08 ILS 14.69 ILS 76
ROIC Compounder 8.00 ILS 9.32 ILS 10.44 ILS 71
Growth Earnings
Growth-Adj P/E 5.42 ILS 7.75 ILS 10.07 ILS 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 53/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 33
How much profit the company makes from its sales and capital
Quality Growth 45
Are margins and returns getting better?
Cashflow 47
Do the profits arrive as real cash?
Financial strength 29
Debt, balance sheet and risk of trouble
Investment 96
Does it invest with discipline instead of growing at any price?
Low Volatility 86
How calm the share price moves, does not count
Price momentum 48
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 45
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−1.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.0%
Start year 2020 (pandemic). Over 10 years: +2.1% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.0%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−34.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−35.0%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−35.0% vs −13.6%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.15% → 3%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−2.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about −4.1% a year for the price.

Watch NISA, get fair value alerts →

Compare Nissan with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks

Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 53 · Below median
Fair Value upside +9.6% · Above median
Profitability
Return on equity (12 months) 4.6% · Below median
Return on assets 1.4% · Below median
Net margin (12 months) 2.5% · Below median
Operating margin (12 months) 11.0% · Below median
Growth and dividend
Revenue growth (quarter YoY) −19.6% · Bottom 25%
Dividend yield (12 months) 0.2% · Bottom 25%
Balance sheet
Debt / equity 0.18× · Above median

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (12 months) 12.1× · Cheapest 25%
P/B 0.43× · Cheapest 25%
P/S (12 months) 0.29× · Cheapest 25%
Price / free cash flow (fiscal year) 7.2× · Cheapest 25%
EV/EBITDA 4.3× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)46 · sector 25
FUTURE (revenue growth)0 · sector 40
PAST (return on equity)18 · sector 30
HEALTH (low debt)91 · sector 96
DIVIDEND (yield)5 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.38 $131.27 +45% vs NISA
EssilorLuxottica Société anonyme EL €193.80 €196.22 +1% vs NISA
Intuitive Surgical, Inc ISRG $452.80 $353.90 −22% vs NISA
Medline Inc MDLN $39.64 $28.59 −28% vs NISA
Alcon Inc ALC CHF 61.30 CHF 34.06 −44% vs NISA
Becton, Dickinson and Company BDX $211.88 $97.80 −54% vs NISA
Straumann Holding STMN CHF 104.50 CHF 45.50 −56% vs NISA
West Pharmaceutical Services, Inc WST $399.81 $139.22 −65% vs NISA
Sartorius Stedim Biotech S.A DIM €225.80 €54.82 −76% vs NISA
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs NISA

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Nissan: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Nissan Fair Value". https://www.fairvalue-calculator.com/stock/NISA

Frequently asked questions

Is Nissan (NISA) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of 10.11 ILS versus a price of 9.53 ILS, about +6% upside (fairly valued).
What is the fair value of NISA?
Our model-based fair value for Nissan is 10.11 ILS (as of Nov 3, 2026), built from audited fundamentals. The current price: 9.53 ILS.
What is the quality score of NISA?
Nissan has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Nissan (NISA)?
Our model-based price target is the fair value of 10.11 ILS (as of Nov 3, 2026) from 24 valuation models. Cautious scenario 8.00 ILS, optimistic scenario 12.63 ILS. It is a calculation from audited fundamentals, not an analyst target.
What is the Nissan stock forecast for 2026?
Our models put fair value at 10.11 ILS, about +6% upside versus a price of 9.53 ILS (fairly valued). Cautious scenario 8.00 ILS, optimistic scenario 12.63 ILS. The calculation is refreshed regularly with new filings.
What is the revenue of Nissan (NISA)?
Nissan reported trailing-twelve-month revenue of about 607M ILS (latest available figure, as of Nov 3, 2026).
Does Nissan pay a dividend?
Nissan currently shows a dividend yield of 0.23% relative to its recent price (as of Nov 3, 2026).
How much is the dividend of Nissan (NISA)?
Nissan has a dividend yield of 0.2%.
What growth is priced into Nissan (NISA)?
For today's price to be fair in a discounted-cash-flow model, Nissan would have to grow free cash flow by -2.1 % per year for five years (discount rate 10.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -2.0 % per year. As of Nov 3, 2026.
What discount rate (WACC) does the fair value of NISA use?
Our models discount Nissan at 10.1 %: a base by market capitalisation (nano), damped by beta 0.07, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Nissan that is -2.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.1 %) and the same formula as our fair value.
How much growth has Nissan (NISA) delivered so far?
Over the past 5 years revenue at Nissan grew -2.0 % a year. The price currently implies free-cash-flow growth of -2.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Nissan (NISA) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Nissan (-2.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Nissan (NISA)?
The free-cash-flow yield on the price is 27.97 %: that much free cash flow Nissan produces per unit of market value. When it exceeds the discount rate of our models (10.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Nissan (NISA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Nissan it is 10.11 ILS per share (as of Nov 3, 2026), against a price of 9.53 ILS. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Nissan stock overvalued or undervalued in 2026?
As of Nov 3, 2026, NISA trades below its calculated fair value: price 9.53 ILS, fair value 10.11 ILS, a gap of about +6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NISA?
No. The price is what the market pays today (9.53 ILS); the fair value is what the company's own numbers justify (10.11 ILS). For Nissan the two are 0.5800 ILS per share apart. That gap is exactly why we show both numbers side by side.
How much is Nissan worth?
The market values Nissan at about 86.6M ILS (market capitalisation, as of Nov 3, 2026). Per share that is 9.53 ILS; our models calculate a fair value of 10.11 ILS per share.
What do the bullish and bearish scenarios say about NISA?
Our models span a range for Nissan: cautious scenario 8.00 ILS, base 10.11 ILS, optimistic 12.63 ILS per share (as of Nov 3, 2026, price 9.53 ILS). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NISA?
Nissan trades at a price-to-earnings ratio of 12.1 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 10.11 ILS is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings: 10.0. Other multiples: P/B 0.4, P/S 0.3, EV/EBITDA 4.3.
How solid is the balance sheet of Nissan (NISA)?
Balance-sheet figures for Nissan (as of Nov 3, 2026): return on equity 4.6%, debt of 0.18 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is NISA from its 52-week high?
Nissan trades at 9.53 ILS, about 14% below its 52-week high of 11.08 ILS and 38% above the low of 6.90 ILS (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 10.11 ILS is for.
Which stocks are comparable to Nissan?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Nissan stock attractive at the current price?
The data as of Nov 3, 2026: price 9.53 ILS, calculated fair value 10.11 ILS (+6%), Quality Score 53/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NISA calculated?
We run Nissan through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 10.11 ILS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Nissan currently trades 6% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Nissan (NISA)?
The closing price on Nov 9, 2026 was 9.53 ILS. Our model-based fair value is 10.11 ILS, about +6% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Nissan right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Where does the earnings growth of Nissan (NISA) come from?
Earnings per share at Nissan grew −9.9 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.5 %, EBIT margin −9.4 %, tax rate +0.8 %, residual (interest, one-offs) −6.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Nissan

How large is the market capitalisation of Nissan (NISA)?
The market capitalisation of Nissan is 86.6M ILS. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Nissan (NISA)?
The price-to-sales ratio of Nissan is 0.15 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Nissan (NISA)?
Earnings per share at Nissan are 0.7900 ILS (price ÷ EPS = P/E 12.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Nissan (NISA)?
The dividend yield of Nissan is 0.2% (payout 2.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Nissan (NISA)?
The net margin of Nissan is 1.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Nissan (NISA)?
The return on equity (ROE) of Nissan is 4.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Nissan (NISA)?
On an EBIT basis the return on assets of Nissan is 4.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Nissan (NISA)?
The operating margin of Nissan is 11.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Nissan (NISA)?
Revenue at Nissan is growing −19.6% versus a year earlier (3y avg −1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Nissan (NISA)?
Earnings per share at Nissan are growing +103% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Nissan (NISA) carry?
The net debt of Nissan is 172M ILS (fiscal year 2025, ≈ 7.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Nissan in the live analysis

One click puts Nissan on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.